C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2004
12/23/2004	US20040260060 Under control of tryptophan operon in prokaryotic host cell; gene overexpression due to point mutations, site-directed mutagenesis, or deletions;
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259256 Methods of unnatural amino acid incorporation in mammalian cells
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259230 Method for producing gamma-glutamylcysteine
12/23/2004	US20040259218 Wood adhesives containing solid residues of biomass fermentations
12/23/2004	US20040259210 Which encode bacteriophage signal peptides; for secretion of antibodies and/or fragment antigen binding fragments; cassettes; host cells
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259151 containing a prosthetic group and/or subunits on the surface of a host cell using the transporter domain of an autotransporter; use of host cell for toxicity monitoring, drug screening or synthesis of organic substances such as enzyme substrates, drugs, hormones, intermediates thereto
12/23/2004	US20040259150 Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259092 Nogo receptor homologues and their use
12/23/2004	US20040259077 Administering antibodies, heavy/light chains, and FAB fragments to treat anaphylactic hypersensitivity, bee stings, snake bites, asthma, allergic rhinitis, eczema, urticaria and food allergies; point mutations
12/23/2004	US20040259075 For blocking entry into cells and inhibiting replication; chemokine receptors
12/23/2004	US20040258691 Treating psoriasis in a patient by administering a therapeutically effective amount of an antibody immunospecific for vetronectin receptor av beta 3; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3; cell adhesion
12/23/2004	US20040258682 Monoclonal antibody or fragment engineered in non-Fc constant heavy or light region; immunoconjugates for cancer diagnosis and therapy
12/23/2004	US20040258680 Methos of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogoues, isoforms and other derivatives
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258672 Graft acceptance through manipulation of thymic regeneration
12/23/2004	DE10235248B4 Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin Fusion protein with enhanced in vivo activity of erythropoietin
12/23/2004	CA2528418A1 Method to increase protein production in culture
12/23/2004	CA2527863A1 Cell surface protein associated with human chronic lymphocytic leukemia
12/22/2004	EP1489188A1 Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489175A1 Modified promoter
12/22/2004	EP1489174A1 Method of modifying protein properties
12/22/2004	EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1489098A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
12/22/2004	EP1489096A1 Novel hemepeptide
12/22/2004	EP1488805A2 CD28 pathway immunoregulation
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488241A1 Arrays
12/22/2004	EP1488231A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
12/22/2004	EP1487981A2 Growth regulating proteins
12/22/2004	EP1487972A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
12/22/2004	EP1487966A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
12/22/2004	EP1487965A2 Minicell compositions and methods
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487868A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487853A2 Secretion, transcription and sporulation genes in bacillus clausii
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487488A1 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487280A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
12/22/2004	EP1235840A4 Methods for identifying compounds that affect rna/rna binding protein interactions
12/22/2004	EP1226230B1 Lactobacillus helveticus producing antihypertensive di- and tripeptides
12/22/2004	EP1177311A4 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
12/22/2004	EP0832253B9 Nucleic acid respiratory syncytial virus vaccines
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	EP0749441B1 Expression and purification of cloned human alpha-fetoprotein
12/22/2004	EP0658200B1 Glucagon receptors
12/22/2004	CN1556859A A method for manufacturing highly-concentrated polyglutamic acid with additional supply of saccharides
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556815A Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease
12/22/2004	CN1556215A Feed supplementing optimization method of saccharomyces pichia fermentation batch process
12/22/2004	CN1556208A Method of preparing polypeptide segment capable of indeperdent expression
12/22/2004	CN1556114A Human dry cell factor macrophage clong irritant factor bifunction protein and its preparation
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181185C Expression of proteolytic enzymes in koji mold in presence of carbon sources
12/22/2004	CN1181093C Extraction of integral membrane proteins
12/21/2004	US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
12/21/2004	US6833441 Compositions and methods for generating chimeric heteromultimers
12/21/2004	US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004	US6833382 Streptogramins and method for preparing same by mutasynthesis
12/21/2004	US6833268 Produced in response to immunization with any desired antigen
12/21/2004	US6833264 Hyaluronan synthase gene and uses therof
12/21/2004	US6833259 Bacteria for use in the generation of xylanase for papermaking
12/21/2004	US6833252 A DNA sequence that can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals; the vectors are useful in gene mapping and site-directed insertion of genes
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	CA2114788C Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004	WO2004108906A2 Bacterial carriers for nucleotide sequences coding for active substances
12/16/2004	WO2004108895A2 Humanized antibodies that recognize beta amyloid peptide
12/16/2004	WO2004108890A2 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
12/16/2004	WO2004108889A2 Hybrid antibodies
12/16/2004	WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
12/16/2004	WO2004107874A1 Method for the preparation of an amino acids-containing solution and use of such a solution
12/16/2004	WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift
12/16/2004	WO2004029218A3 Receptors and membrane-associated proteins
12/16/2004	WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
12/16/2004	WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004	WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same
12/16/2004	WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
12/16/2004	WO2003005953A3 Viral proteins capable of binding lar
12/16/2004	WO2002070665A8 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
12/16/2004	US20040255347 Using site specific recombination to insert heterologous nucleotide sequences into plants tissue; enhancing nutrient quality of plants; bioreactors
12/16/2004	US20040254363 Genes and snps associated with eating disorders
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254347 Immobilizing tetrapeptide to solid support via exposure to transglutaminase for use as tool in enhancing immune response; immunotherapy
12/16/2004	US20040254346 Human survivin interacting protein 1 (sip-1)

1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 1125